Snowden Capital Advisors LLC Ironwood Pharmaceuticals Inc Transaction History

Snowden Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $2,122 - $2,576	-200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $2,172 - $2,790	200 New	200 $2,000
Q1 2020 Jan 08, 2024	SELL	$8.58 - $14.01 $171,600 - $280,200	-20,000 Closed	0 $0
Q4 2019 Jan 08, 2024	BUY	$8.22 - $14.0 $164,400 - $280,000	20,000 New	20,000 $2.66 Million
Q3 2019 Jan 08, 2024	SELL	$8.59 - $10.96 $136,581 - $174,264	-15,900 Closed	0 $0
Q2 2019 Jan 08, 2024	BUY	$9.8 - $12.89 $155,820 - $204,951	15,900 New	15,900 $2.19 Million

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $682M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.